FPR2 and myocardial infarction: In fact, in a murine model of acute MI, administration of the synthetic FPR2 agonist WKYMVm provides cardiac protection by mobilizing circulating angiogenic cells, such as endothelial progenitor cells, thus contributing to their homing to ischemic heart in an FPR2-dependent manner [62].